ACE2 and adenocarcinoma: No significant difference in expression of ACE2, TMPRSS2, or cathepsin L between patients with adenocarcinoma and squamous cell carcinoma (Supplementary Figure 8), suggesting types of lung cancer show no effect on expression of SARS-CoV-2 entry genes.